There is increasing evidence to indicate that the ERK5 signaling takes part in the development and progression of several types of cancers, including breast cancer, myeloma, lymphoma, leukemia (Stecca & Rovida, 2019). This evidence concerns the gene MAPK7 and lymphoma.